Bringing technology to market: National Heart, Lung, and Blood Institute SBIR Phase IIB projects

IF 2.6 4区管理学 Q2 ENVIRONMENTAL STUDIES

Science and Public Policy Pub Date : 2023-10-12 DOI:10.1093/scipol/scad063

Sara Nienow, Olena Leonchuk, Alan C O’Connor, Albert N Link

引用次数: 0

Abstract

Abstract The National Heart, Lung, and Blood Institute (NHLBI) is the fourth largest institute in the US National Institutes of Health (NIH). Surprisingly, there is a conspicuous void of policy studies related to the research activities of NHLBI in comparison to NIH or the National Cancer Institute. This paper investigates the likelihood that a business funded through NHLBI’s Small Business Innovation Research (SBIR) program will commercialize from its Phase IIB translational support. Commercialization is one performance metric that quantifies a policy dimension of the success of the funded SBIR project. Based on an empirical analysis of sixty-one Phase IIB projects, we find that the most significant covariate with the likelihood of commercialization is the growth in human capital within the business since the Phase IIB award.

查看原文本刊更多论文

将技术推向市场:国家心脏、肺和血液研究所SBIR二期ib项目

美国国家心肺血液研究所(NHLBI)是美国国立卫生研究院(NIH)的第四大研究所。令人惊讶的是，与NIH或国家癌症研究所相比，与NHLBI的研究活动相关的政策研究明显缺乏。本文调查了通过NHLBI的小企业创新研究(SBIR)项目资助的企业将从其IIB阶段的转化支持中商业化的可能性。商业化是一种性能度量，它量化了所资助的SBIR项目成功的策略维度。基于对61个IIB阶段项目的实证分析，我们发现与商业化可能性最显著的协变量是自IIB阶段奖励以来企业内部人力资本的增长。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Science and Public Policy Multiple-

CiteScore

4.50

自引率

11.10%

发文量

期刊介绍： Science and Public Policy is a leading refereed, international journal on public policies for science, technology and innovation, and on their implications for other public policies. It covers basic, applied, high, low, and any other types of S&T, and rich or poorer countries. It is read in around 70 countries, in universities (teaching and research), government ministries and agencies, consultancies, industry and elsewhere.